Medical Devices - Kiryat Ono, Tel Aviv District, Israel
R&D, Quality, Clinical and Regulatory Affairs
MIMS® creates a drainage channel to reduce IOP in Glaucoma patients, ensuring a long-lasting safe and controlled fluid flow, no stitches, eye-patch, implant or stent. It is designed to reduce the caring costs of Glaucomatous patients' through simplicity, low cost, fewer post-surgical complications and less hospitalization.• A novel Glaucoma treatment• Leaves nothing behind (stent-less) thus lowering the risk of complications• Can be easily combined with Cataract surgery• Medication-sparing which improves patients' quality of life
Gmail
Cloudinary
Mobile Friendly